We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Safety, Pharmacodynamics and Pharmacokinetics of GSK2136525 Repeat Dose in Rheumatoid Arthritis

This study has been terminated.
(The risk-benefit ratio for patients has changed since we initiated the study, and that the study in its current form cannot be justified)
Sponsor:
ClinicalTrials.gov Identifier:
NCT01077531
First Posted: March 1, 2010
Last Update Posted: June 8, 2017
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by (Responsible Party):
GlaxoSmithKline
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: March 19, 2013
  Primary Completion Date: March 19, 2013 (Final data collection date for primary outcome measure)